Shared Genetic basis for type 1 diabetes, islet autoantibodies, and autoantibodies associated with other immune-mediated diseases in families with type 1 diabetes

Diabetes Care

Volumn 38, Issue , 2015, Pages S8-S13

  Brorsson, Caroline A ^a,b   Pociot, Flemming ^b  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

21 HYDROXYLASE ANTIBODY; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE ANTIBODY; PANCREAS ISLET CELL ANTIBODY; PARIETAL CELL ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY; THYROID PEROXIDASE ANTIBODY; UNCLASSIFIED DRUG; ZINC TRANSPORTER 8 ANTIBODY; AUTOANTIGEN;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AUTOIMMUNE THYROIDITIS; BACH2 GENE; CELIAC DISEASE; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; CTLA4 GENE; FAMILY; FEMALE; GASTRITIS; GENE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HEREDITY; HUMAN; IFIH1 GENE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PTPN22 GENE; SH2B3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; IMMUNOLOGY; MIDDLE AGED; NEWBORN; PANCREAS ISLET; PRESCHOOL CHILD; STOMACH PARIETAL CELL; YOUNG ADULT;

ADOLESCENT; ADRENAL INSUFFICIENCY; ADULT; AUTOANTIBODIES; AUTOANTIGENS; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; GASTRITIS; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; INFANT; INFANT, NEWBORN; ISLETS OF LANGERHANS; MIDDLE AGED; PARIETAL CELLS, GASTRIC; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84965186550     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dcs15-2003     Document Type: Conference Paper

References (43)

1. Barrett JC, Clayton DG, Concannon P, et al.; Type 1 Diabetes Genetics Consortium. Genomewide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 2009;41:703-707
2. Achenbach P,Warncke K, Reiter J, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004;53:384-392
3. Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A 2007;104:17040-17045
4. Howson JM, Stevens H, Smyth DJ, et al. Evidence that HLA class I and II associations with type 1 diabetes, autoantibodies to GAD and autoantibodies to IA-2, are distinct. Diabetes 2011;60:2635-2644
5. Qu HQ, Polychronakos C. The effect of the MHC locus on autoantibodies in type 1 diabetes. J Med Genet 2009;46:469-471
6. Plagnol V, Howson JM, Smyth DJ, et al.; Type 1 Diabetes Genetics Consortium. Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet 2011;7: e1002216
7. Howson JM, Krause S, Stevens H, et al. Genetic association of zinc transporter 8 (ZnT8) autoantibodies in type 1 diabetes cases. Diabetologia 2012;55:1978-1984
8. Pociot F, Akolkar B, Concannon P, et al. Genetics of type 1 diabetes: what's next? Diabetes 2010;59:1561-1571
9. Rich SS, Concannon P, Erlich H, et al. The Type 1 Diabetes Genetics Consortium. Ann N Y Acad Sci 2006;1079:1-8
10. Akolkar B, Hilner J, Nierras CR. Design and measurement of nonislet-specific autoantibodies for the Type 1 Diabetes Genetics Consortium Autoantibody Workshop. Diabetes Care 2015; 38(Suppl. 2):S4-S7
11. Wenzlau JM, Frisch LM, Hutton JC, Fain PR, Davidson HW. Changes in zinc transporter 8 autoantibodies following type 1 diabetes onset: the Type 1 Diabetes Genetics Consortium Autoantibody Workshop. Diabetes Care 2015; 38(Suppl. 2):S14-S20
12. Halekoh U, Hojsgaard S, Yan J. The R Package geepack for generalized estimating equations. J Stat Softw 2006;15:1-11
13. Liang KY, Zeger SL. Longitudinal data-analysis using generalized linear-models. Biometrika 1986; 73:13-22
14. Barker JM, Triolo TM, Aly TA, et al. Two single nucleotide polymorphisms identify the highestrisk diabetes HLA genotype: potential for rapid screening. Diabetes 2008;57:3152-3155
15. Romanos J, Wijmenga C. Comment on: Barker et al. (2008) Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: Diabetes 57:3152-3155, 2008. Diabetes 2009;58:e1
16. Tomer Y. Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 2010;20:715-725
17. Trynka G, Hunt KA, Bockett NA, et al.; Spanish Consortium on the Genetics of Coeliac Disease (CEGEC); PreventCD Study Group; Wellcome Trust Case Control Consortium (WTCCC). Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat Genet 2011;43: 1193-1201
18. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-2777
19. Sutherland A, Davies J, Owen CJ, et al. Genomic polymorphism at the interferon-induced helicase (IFIH1) locus contributes to Graves' disease susceptibility. J Clin Endocrinol Metab 2007;92:3338-3341
20. Chu X, Pan CM, Zhao SX, et al.; China Consortium for Genetics of Autoimmune Thyroid Disease. A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet 2011;43:897-901
21. Burton PR, Clayton DG, Cardon LR, et al.; Wellcome Trust Case Control Consortium; Australo-Anglo-American Spondylitis Consortium (TASC); Biologics in RA Genetics and Genomics Study Syndicate (BRAGGS) Steering Committee; Breast Cancer Susceptibility Collaboration (UK). Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007;39:1329-1337
22. Meylan E, Tschopp J, Karin M. Intracellular pattern recognition receptors in the host response. Nature 2006;442:39-44
23. Lönnrot M, Korpela K, Knip M, et al. Enterovirus infection as a risk factor for beta-cell autoimmunity in a prospectively observed birth cohort: the Finnish Diabetes Prediction and Prevention Study. Diabetes 2000;49:1314-1318
24. Smyth DJ, Cooper JD, Bailey R, et al. A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 2006;38:617-619
25. Colli ML, Moore F, Gurzov EN, Ortis F, Eizirik DL. MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. Hum Mol Genet 2010;19:135-146
26. Bottini N, Musumeci L, Alonso A, et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat Genet 2004;36:337-338
27. Vang T, Congia M, Macis MD, et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat Genet 2005;37:1317-1319
28. Smyth D, Cooper JD, Collins JE, et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes 2004;53: 3020-3023
29. Skinningsrud B, Husebye ES, Gervin K, et al. Mutation screening of PTPN22: association of the 1858T-allele with Addison's disease. Eur J Hum Genet 2008;16:977-982
30. Roycroft M, Fichna M, McDonald D, et al. The tryptophan 620 allele of the lymphoid tyrosine phosphatase (PTPN22) gene predisposes to autoimmune Addison's disease. Clin Endocrinol (Oxf) 2009;70:358-362
31. Li Y, He X, Schembri-King J, Jakes S, Hayashi J. Cloning and characterization of human Lnk, an adaptor protein with pleckstrin homology and Src homology 2 domains that can inhibit T cell activation. J Immunol 2000;164:5199-5206
32. Muto A, Tashiro S, Nakajima O, et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 2004;429:566-571
33. Marroquí L, Santin I, Dos Santos RS, Marselli L, Marchetti P, Eizirik DL. BACH2, a candidate risk gene for type 1 diabetes, regulates apoptosis in pancreatic b-cells via JNK1 modulation and crosstalk with the candidate gene PTPN2. Diabetes 2014;63:2516-2527
34. Donner H, Braun J, Seidl C, et al. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J Clin Endocrinol Metab 1997;82:4130-4132
35. Kotsa K, Watson PF, Weetman APA. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin Endocrinol (Oxf) 1997;46: 551-554
36. Teft WA, Kirchhof MG, Madrenas J. A molecular perspective of CTLA-4 function. Annu Rev Immunol 2006;24:65-97
37. Graham J, Hagopian WA, Kockum I, et al.; Diabetes Incidence in Sweden Study Group; Swedish Childhood Diabetes Study Group. Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes. Diabetes 2002;51:1346-1355
38. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 1989;169:345-350
39. Arentz-Hansen H, Körner R, Molberg O, et al. The intestinal T cell response to alphagliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000;191: 603-612
40. Simmonds MJ, Howson JM, Heward JM, et al. Regression mapping of association between the human leukocyte antigen region and Graves disease. Am J Hum Genet 2005;76: 157-163
41. Jacobson EM, Huber A, Tomer Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 2008; 30:58-62
42. Skinningsrud B, Lie BA, Lavant E, et al. Multiple loci in the HLA complex are associated with Addison's disease. J Clin Endocrinol Metab 2011;96:E1703-E1708
43. Parkes M, Cortes A, van Heel DA, Brown MA. Genetic insights into common pathways and complex relationships among immunemediated diseases. Nat Rev Genet 2013;14: 661-673